(Q36557330)

14 August 2017

1 reference

title

Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities (English)

1 reference

14 August 2017

0 references

2

1 reference

14 August 2017

3

Francois Dabis

1 reference

14 August 2017

4

Jean-Louis Excler

1 reference

14 August 2017

1

Katherine Luzuriaga

1 reference

14 August 2017

John L Sullivan

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

368

1 reference

14 August 2017

issue

9534

1 reference

14 August 2017

page(s)

511-521

1 reference

Medicine. The need for a global HIV vaccine enterprise

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Advances in the prevention of vertical transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Primary HIV-1 infection in African children infected through breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Prevention of Mother‐to‐Child Transmission of HIV‐1 through Breast‐Feeding: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Breast-feeding and HIV-1 transmission in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

HIV transmission through breastfeeding: a study in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Breast-feeding and Transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Older children and adolescents surviving with vertically acquired HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobuli

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

HIV-1-specific CD8+ T cell responses and viral evolution in women and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Immunoprophylaxis to prevent mother-to-child transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

HIV-1 prophylactic vaccine trials in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Immunologic profile of highly exposed yet HIV type 1-seronegative men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Modified vaccinia Ankara: potential as an alternative smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Viral etiology of intussusception in Taiwanese childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

DNA vaccines: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969159-9

7 January 2021

10.1016/S0140-6736(06)69159-9

Identifiers

DOI

1 reference

14 August 2017

1 reference